[ad_1]
The occurrence of Covid -19 has worked as a boon for peptide synthesis market, as adoption of the process has increased for vaccine and drug research and development programs
DUBAI, United Arab Emirates, Feb. 07, 2022 (GLOBE NEWSWIRE) — As per the peptide synthesis market survey by Future Market Insights (FMI), the peptide synthesis market is forecasted to register a CAGR of 7% from 2022 to 2032.
| Attributes | Details | |
| Peptide Synthesis Market CAGR (2022 – 2032) | 7% | |
| Peptide Synthesis Market (2026) | US$ 720 Mn | |
| Peptide Synthesis Market Attraction | Asia Pacific to highest witness growth and North America to maintain dominance |
|
Growth in this market is mainly influenced by the prevalence of a wide range of applications of peptides in the treatment of various lifestyle disorders, such as cancers, diabetes, and obesity.
Owing to their large chemical space, high biological activity, and low toxicity, peptide synthesis in pharmaceutical manufacturing is increasingly being considered as active in drug development and in turn is expected to flourish the peptide synthesis market and rise the adoption of peptide synthesis process.
Peptides generate billions of dollars in revenue in oncology, diabetes, and obesity, among other therapeutic areas.
Request for Report Sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-14257
The COVID-19 pandemic has prompted major pharmaceutical and biotechnology firms, as well as peptide synthesis firms, to invest in therapeutic and peptide-based vaccine research and development. Also, peptide synthesis has risen to the forefront due to increased demand for peptide synthesis drugs and vaccines.
The peptide-based approach marks a pivotal point as peptides have demonstrated unique selectivity and specificity toward specific targets.
CoVac-1 is a peptide-based vaccine candidate that combines SARS-CoV-2 T-cell epitopes derived from various viral proteins with the Toll-like receptor 1/2 agonist XS15 emulsified in Montanide ISA51 VG, with the goal of inducing profound SARS -CoV-2 T-cell immunity to combat COVID-19.
Such advancements have resulted in an emerging trend in peptide synthesis market, thereby surged the demand for reagents and equipment used in the production of peptides.
The lack of a unified set of regulations has made obtaining approvals for therapeutic peptides toilsome, limiting their application areas. This is regarded as a major impediment to the growth of the global peptide synthesis market.
Considering all of the above-mentioned factors, the peptide synthesis market size is expected to be around US$ 720 Mn by 2026.
Key Takeaways
- Peptide synthesis market future trends suggests that the market is anticipated to be dominated by the reagents segment.
- The historical performance of the peptide synthesis market was modest with the valuation of US$ 514 in 2021.
- The APAC peptide synthesis market is expected to continue to grow at the fastest rate, owing to increased investments by pharmaceutical as well as increased R&D activities in the region’s countries.
- Based on end use, pharmaceutical and biotechnology companies are expected to hold a significant market share due to the increasing use of peptides for therapeutic drug development.
- By technology, the segment of solid-phase peptide synthesis is expected to advance at faster pace due to ease of peptide purification.
Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-14257
“High prevalence of chronic diseases, and increased investments in the development of structure-based drug designs can all be attributed to North America’s …
Full story available on Benzinga.com
[ad_2]
Source link
